{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:56:19Z","timestamp":1792511779393,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"28","license":[{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073198"],"award-info":[{"award-number":["82073198"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2024,7,5]]},"DOI":"10.1038\/s41388-024-03072-7","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T14:02:30Z","timestamp":1716818550000},"page":"2215-2227","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Bone-metastatic lung adenocarcinoma cells bearing CD74-ROS1 fusion interact with macrophages to promote their dissemination"],"prefix":"10.1038","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5603-8152","authenticated-orcid":false,"given":"Zhao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0320-0377","authenticated-orcid":false,"given":"Shengjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5972-3383","authenticated-orcid":false,"given":"Ersuo","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7908-0106","authenticated-orcid":false,"given":"Runfeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4182-421X","authenticated-orcid":false,"given":"Hong-Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,27]]},"reference":[{"key":"3072_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"3072_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115\u201332.","journal-title":"CA Cancer J Clin"},{"key":"3072_CR3","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature13385","volume":"511","author":"N Cancer Genome Atlas Research","year":"2014","unstructured":"Cancer Genome Atlas Research N. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014;511:543\u201350.","journal-title":"Nature"},{"key":"3072_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111513","volume":"41","author":"Z Su","year":"2022","unstructured":"Su Z, Sun Z, Wang Z, Wang S, Wang Y, Jin E, et al. TIF1\u03b3 inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15\/TBP complex. Cell Rep. 2022;41:111513.","journal-title":"Cell Rep"},{"key":"3072_CR5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/JTO.0b013e31819518fc","volume":"4","author":"H Al Husaini","year":"2009","unstructured":"Al Husaini H, Wheatley-Price P, Clemons M, Shepherd FA. Prevention and management of bone metastases in lung cancer: a review. J Thorac Oncol. 2009;4:251\u20139.","journal-title":"J Thorac Oncol"},{"key":"3072_CR6","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1002\/cncr.21778","volume":"106","author":"KR Hess","year":"2006","unstructured":"Hess KR, Varadhachary GR, Taylor SH, Wei W, Raber MN, Lenzi R, et al. Metastatic patterns in adenocarcinoma. Cancer. 2006;106:1624\u201333.","journal-title":"Cancer"},{"key":"3072_CR7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.lungcan.2014.07.020","volume":"86","author":"M Riihimaki","year":"2014","unstructured":"Riihimaki M, Hemminki A, Fallah M, Thomsen H, Sundquist K, Sundquist J, et al. Metastatic sites and survival in lung cancer. Lung Cancer. 2014;86:78\u201384.","journal-title":"Lung Cancer"},{"key":"3072_CR8","doi-asserted-by":"publisher","first-page":"6047","DOI":"10.3390\/ijms20236047","volume":"20","author":"R Zajaczkowska","year":"2019","unstructured":"Zajaczkowska R, Kocot-Kepska M, Leppert W, Wordliczek J. Bone pain in cancer patients: mechanisms and current treatment. Int J Mol Sci. 2019;20:6047.","journal-title":"Int J Mol Sci"},{"key":"3072_CR9","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1152\/physrev.00012.2019","volume":"101","author":"P Clezardin","year":"2021","unstructured":"Clezardin P, Coleman R, Puppo M, Ottewell P, Bonnelye E, Paycha F, et al. Bone metastasis: mechanisms, therapies, and biomarkers. Physiol Rev. 2021;101:797\u2013855.","journal-title":"Physiol Rev"},{"key":"3072_CR10","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1016\/j.cell.2021.03.011","volume":"184","author":"W Zhang","year":"2021","unstructured":"Zhang W, Bado IL, Hu J, Wan YW, Wu L, Wang H, et al. The bone microenvironment invigorates metastatic seeds for further dissemination. Cell. 2021;184:2471\u20132486.e2420.","journal-title":"Cell"},{"key":"3072_CR11","first-page":"98","volume":"8","author":"S Paget","year":"1989","unstructured":"Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev. 1989;8:98\u2013101.","journal-title":"Cancer Metastasis Rev"},{"key":"3072_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10555-016-9618-0","volume":"35","author":"HH Popper","year":"2016","unstructured":"Popper HH. Progression and metastasis of lung cancer. Cancer Metastasis Rev. 2016;35:75\u201391.","journal-title":"Cancer Metastasis Rev"},{"key":"3072_CR13","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.devcel.2021.03.008","volume":"56","author":"IL Bado","year":"2021","unstructured":"Bado IL, Zhang W, Hu J, Xu Z, Wang H, Sarkar P, et al. The bone microenvironment increases phenotypic plasticity of ER(+) breast cancer cells. Dev Cell. 2021;56:1100\u20131117.e1109.","journal-title":"Dev Cell"},{"key":"3072_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1172\/JCI22320","volume":"115","author":"AJ Minn","year":"2005","unstructured":"Minn AJ, Kang Y, Serganova I, Gupta GP, Giri DD, Doubrovin M, et al. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest. 2005;115:44\u201355.","journal-title":"J Clin Invest"},{"key":"3072_CR15","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko I, Blanpain C. EMT transition states during tumor progression and metastasis. Trends Cell Biol. 2019;29:212\u201326.","journal-title":"Trends Cell Biol"},{"key":"3072_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41568-021-00370-0","volume":"21","author":"S Seton-Rogers","year":"2021","unstructured":"Seton-Rogers S. Metastases arrive at other organs via bone. Nat Rev Cancer. 2021;21:411.","journal-title":"Nat Rev Cancer"},{"key":"3072_CR17","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.semcancer.2013.08.007","volume":"23","author":"V Catalano","year":"2013","unstructured":"Catalano V, Turdo A, Di Franco S, Dieli F, Todaro M, Stassi G. Tumor and its microenvironment: a synergistic interplay. Semin Cancer Biol. 2013;23:522\u201332.","journal-title":"Semin Cancer Biol"},{"key":"3072_CR18","first-page":"37","volume":"1795","author":"J Acquaviva","year":"2009","unstructured":"Acquaviva J, Wong R, Charest A. The multifaceted roles of the receptor tyrosine kinase ROS in development and cancer. Biochim Biophys Acta. 2009;1795:37\u201352.","journal-title":"Biochim Biophys Acta"},{"key":"3072_CR19","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1200\/JCO.2011.35.6345","volume":"30","author":"K Bergethon","year":"2012","unstructured":"Bergethon K, Shaw AT, Ou SH, Katayama R, Lovly CM, McDonald NT, et al. ROS1 rearrangements define a unique molecular class of lung cancers. J Clin Oncol. 2012;30:863\u201370.","journal-title":"J Clin Oncol"},{"key":"3072_CR20","doi-asserted-by":"publisher","first-page":"4570","DOI":"10.1158\/1078-0432.CCR-12-0550","volume":"18","author":"KD Davies","year":"2012","unstructured":"Davies KD, Le AT, Theodoro MF, Skokan MC, Aisner DL, Berge EM, et al. Identifying and targeting ROS1 gene fusions in non-small cell lung cancer. Clin Cancer Res. 2012;18:4570\u20139.","journal-title":"Clin Cancer Res"},{"key":"3072_CR21","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1097\/JTO.0b013e31826baf83","volume":"7","author":"LP Chin","year":"2012","unstructured":"Chin LP, Soo RA, Soong R, Ou SH. Targeting ROS1 with anaplastic lymphoma kinase inhibitors: a promising therapeutic strategy for a newly defined molecular subset of non-small-cell lung cancer. J Thorac Oncol. 2012;7:1625\u201330.","journal-title":"J Thorac Oncol"},{"key":"3072_CR22","first-page":"156","volume":"4","author":"T Kohno","year":"2015","unstructured":"Kohno T, Nakaoku T, Tsuta K, Tsuchihara K, Matsumoto S, Yoh K, et al. Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer. Transl Lung Cancer Res. 2015;4:156\u201364.","journal-title":"Transl Lung Cancer Res"},{"key":"3072_CR23","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"3072_CR24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrc.2016.25","volume":"16","author":"PS Steeg","year":"2016","unstructured":"Steeg PS. Targeting metastasis. Nat Rev Cancer. 2016;16:201\u201318.","journal-title":"Nat Rev Cancer"},{"key":"3072_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0976-4","volume":"18","author":"C Wei","year":"2019","unstructured":"Wei C, Yang C, Wang S, Shi D, Zhang C, Lin X, et al. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis. Mol Cancer. 2019;18:64.","journal-title":"Mol Cancer"},{"key":"3072_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.583084","volume":"11","author":"Y Pan","year":"2020","unstructured":"Pan Y, Yu Y, Wang X, Zhang T. Tumor-associated macrophages in tumor immunity. Front Immunol. 2020;11:583084.","journal-title":"Front Immunol"},{"key":"3072_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202002054","volume":"32","author":"Y Xia","year":"2020","unstructured":"Xia Y, Rao L, Yao H, Wang Z, Ning P, Chen X. Engineering macrophages for cancer immunotherapy and drug delivery. Adv Mater. 2020;32:e2002054.","journal-title":"Adv Mater"},{"key":"3072_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05093-0","volume":"13","author":"Z Wang","year":"2022","unstructured":"Wang Z, Chen J, Wang S, Sun Z, Lei Z, Zhang HT, et al. RGS6 suppresses TGF-\u03b2-induced epithelial-mesenchymal transition in non-small cell lung cancers via a novel mechanism dependent on its interaction with SMAD4. Cell Death Dis. 2022;13:656.","journal-title":"Cell Death Dis"},{"key":"3072_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67325-7","volume":"10","author":"BN Kim","year":"2020","unstructured":"Kim BN, Ahn DH, Kang N, Yeo CD, Kim YK, Lee KY, et al. TGF-\u03b2 induced EMT and stemness characteristics are associated with epigenetic regulation in lung cancer. Sci Rep. 2020;10:10597.","journal-title":"Sci Rep"},{"key":"3072_CR30","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202052079","volume":"22","author":"S Wang","year":"2021","unstructured":"Wang S, Tong X, Li C, Jin E, Su Z, Sun Z, et al. Quaking 5 suppresses TGF-\u03b2-induced EMT and cell invasion in lung adenocarcinoma. EMBO Rep. 2021;22:e52079.","journal-title":"EMBO Rep"},{"key":"3072_CR31","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.cell.2007.11.025","volume":"131","author":"K Rikova","year":"2007","unstructured":"Rikova K, Guo A, Zeng Q, Possemato A, Yu J, Haack H, et al. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell. 2007;131:1190\u2013203.","journal-title":"Cell"},{"key":"3072_CR32","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nrc867","volume":"2","author":"GR Mundy","year":"2002","unstructured":"Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer. 2002;2:584\u201393.","journal-title":"Nat Rev Cancer"},{"key":"3072_CR33","first-page":"103","volume":"20","author":"L Ye","year":"2007","unstructured":"Ye L, Kynaston HG, Jiang WG. Bone metastasis in prostate cancer: molecular and cellular mechanisms (Review). Int J Mol Med. 2007;20:103\u201311.","journal-title":"Int J Mol Med"},{"key":"3072_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/sj.cr.7290266","volume":"15","author":"JJ Yin","year":"2005","unstructured":"Yin JJ, Pollock CB, Kelly K. Mechanisms of cancer metastasis to the bone. Cell Res. 2005;15:57\u201362.","journal-title":"Cell Res"},{"key":"3072_CR35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrc1098","volume":"3","author":"IJ Fidler","year":"2003","unstructured":"Fidler IJ. The pathogenesis of cancer metastasis: the \u2018seed and soil\u2019 hypothesis revisited. Nat Rev Cancer. 2003;3:453\u20138.","journal-title":"Nat Rev Cancer"},{"key":"3072_CR36","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19:1423\u201337.","journal-title":"Nat Med"},{"key":"3072_CR37","first-page":"2281","volume":"40","author":"IR Hart","year":"1980","unstructured":"Hart IR, Fidler IJ. Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer Res. 1980;40:2281\u20137.","journal-title":"Cancer Res"},{"key":"3072_CR38","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/bjc.1987.13","volume":"55","author":"RE Coleman","year":"1987","unstructured":"Coleman RE, Rubens RD. The clinical course of bone metastases from breast cancer. Br J Cancer. 1987;55:61\u201366.","journal-title":"Br J Cancer"},{"key":"3072_CR39","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1172\/JCI96149","volume":"128","author":"I Ullah","year":"2018","unstructured":"Ullah I, Karthik GM, Alkodsi A, Kjallquist U, Stalhammar G, Lovrot J, et al. Evolutionary history of metastatic breast cancer reveals minimal seeding from axillary lymph nodes. J Clin Invest. 2018;128:1355\u201370.","journal-title":"J Clin Invest"},{"key":"3072_CR40","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.ccell.2020.10.004","volume":"38","author":"G Chang","year":"2020","unstructured":"Chang G, Shi L, Ye Y, Shi H, Zeng L, Tiwary S, et al. YTHDF3 Induces the Translation of m(6)A-enriched gene transcripts to promote breast cancer brain metastasis. Cancer Cell. 2020;38:857\u2013871.e857.","journal-title":"Cancer Cell"},{"key":"3072_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2021.100440","volume":"28","author":"Y Takahara","year":"2021","unstructured":"Takahara Y, Nakase K, Nojiri M, Kato R, Shinomiya S, Oikawa T, et al. Relationship between clinical features and gene mutations in non-small cell lung cancer with osteoblastic bone metastasis. Cancer Treat Res Commun. 2021;28:100440.","journal-title":"Cancer Treat Res Commun"},{"key":"3072_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15016","volume":"8","author":"H Zhang","year":"2017","unstructured":"Zhang H, Deng T, Liu R, Bai M, Zhou L, Wang X, et al. Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis. Nat Commun. 2017;8:15016.","journal-title":"Nat Commun"},{"key":"3072_CR43","doi-asserted-by":"publisher","first-page":"3873","DOI":"10.1158\/1078-0432.CCR-18-3421","volume":"25","author":"Y Nie","year":"2019","unstructured":"Nie Y, Huang H, Guo M, Chen J, Wu W, Li W, et al. Breast phyllodes tumors recruit and repolarize tumor-associated macrophages via secreting CCL5 to promote malignant progression, which can be inhibited by CCR5 inhibition therapy. Clin Cancer Res. 2019;25:3873\u201386.","journal-title":"Clin Cancer Res"},{"key":"3072_CR44","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1007\/s12272-016-0820-y","volume":"39","author":"I Rhee","year":"2016","unstructured":"Rhee I. Diverse macrophages polarization in tumor microenvironment. Arch Pharm Res. 2016;39:1588\u201396.","journal-title":"Arch Pharm Res"},{"key":"3072_CR45","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.trecan.2019.10.007","volume":"5","author":"K Mehla","year":"2019","unstructured":"Mehla K, Singh PK. Metabolic Regulation of macrophage polarization in cancer. Trends Cancer. 2019;5:822\u201334.","journal-title":"Trends Cancer"},{"key":"3072_CR46","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1158\/0008-5472.CAN-11-2493","volume":"72","author":"LY Chang","year":"2012","unstructured":"Chang LY, Lin YC, Mahalingam J, Huang CT, Chen TW, Kang CW, et al. Tumor-derived chemokine CCL5 enhances TGF-\u03b2-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells. Cancer Res. 2012;72:1092\u2013102.","journal-title":"Cancer Res"},{"key":"3072_CR47","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson DE, O\u2019Keefe RA, Grandis JR. Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018;15:234\u201348.","journal-title":"Nat Rev Clin Oncol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-03072-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-03072-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-03072-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T06:02:03Z","timestamp":1720159323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-03072-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,27]]},"references-count":47,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2024,7,5]]}},"alternative-id":["3072"],"URL":"https:\/\/doi.org\/10.1038\/s41388-024-03072-7","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,27]]},"assertion":[{"value":"9 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Human NSCLC tissues were collected after informed consent was obtained from all patients. The study protocol was conducted in accordance with the Declaration of Helsinki and has been approved by the Ethics Committee of the First Affiliated Hospital of Soochow University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Declarations"}}]}}